Nan Fung Group Holdings Ltd 13F Holdings · Q2 2026
Nan Fung Group Holdings Ltd reported 25 securities worth $131.49M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: MPLT (26.47%), LBRX (15.57%), EVMN (14.56%). Among its top 25 positions this quarter: 2 new, 1 added, 2 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MPLT | MAPLIGHT THERAPEUTICS INC | $34.8M | 26.47% | 971,253 | Hold |
| 2 | LBRX | LB PHARMACEUTICALS INC | $20.5M | 15.57% | 630,657 | Hold |
| 3 | EVMN | EVOMMUNE INC | $19.2M | 14.56% | 1.4M | Hold |
| 4 | HELP | CYBIN INC | $6.5M | 4.96% | 987,222 | Added |
| 5 | INCY | INCYTE CORP | $6.1M | 4.63% | 53,742 | Hold |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | $5.5M | 4.15% | 49,120 | Hold |
| 7 | ONC | BEONE MEDICINES LTD | $4.5M | 3.41% | 15,722 | Hold |
| 8 | OCS | OCULIS HOLDING AG | $4.2M | 3.17% | 300,565 | Trimmed |
| 9 | ASND | ASCENDIS PHARMA A/S | $3.6M | 2.76% | 13,600 | New |
| 10 | RVMD | REVOLUTION MEDICINES INC | $3.6M | 2.74% | 19,253 | Hold |
| 11 | KYMR | KYMERA THERAPEUTICS INC | $3.5M | 2.69% | 30,875 | Hold |
| 12 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.0M | 2.32% | 5,672 | Hold |
| 13 | CELC | CELCUITY INC | $3.0M | 2.25% | 28,300 | Hold |
| 14 | ACAD | ACADIA PHARMACEUTICALS INC | $2.6M | 1.98% | 102,984 | Hold |
| 15 | ARGX | ARGENX SE | $2.6M | 1.98% | 2,800 | Hold |
| 16 | RXRX | RECURSION PHARMACEUTICALS IN | $2.2M | 1.66% | 595,287 | Hold |
| 17 | PCOR | PROCORE TECHNOLOGIES INC | $2.2M | 1.65% | 53,299 | Hold |
| 18 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $984,854 | 0.75% | 27,049 | Hold |
| 19 | INSM | INSMED INC | $701,560 | 0.53% | 6,580 | Hold |
| 20 | ETHA | ISHARES ETHEREUM TR | $601,028 | 0.46% | 50,549 | Hold |
| 21 | IBIT | ISHARES BITCOIN TRUST ETF | $531,575 | 0.40% | 15,968 | Hold |
| 22 | CHYM | CHIME FINL INC | $431,616 | 0.33% | 21,075 | New |
| 23 | RANI | RANI THERAPEUTICS HLDGS INC | $375,321 | 0.29% | 493,584 | Hold |
| 24 | TRDA | ENTRADA THERAPEUTICS INC | $361,244 | 0.27% | 49,082 | Hold |
| 25 | BOLT | BOLT BIOTHERAPEUTICS INC | $19,250 | 0.01% | 5,000 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR